Fadogia Agrestis
Fadogia agrestis is a Nigerian shrub traditionally used in folk medicine as an aphrodisiac and pro-fertility agent. It has gained popularity in the supplement market for its purported ability to support testosterone production and male reproductive health.
Overview
Fadogia agrestis is a plant belonging to the Rubiaceae family, native to West Africa, where it has been used for centuries in traditional medicine to treat erectile dysfunction, increase libido, and support male vitality. The stem of the plant is the primary part used in herbal preparations, and its bioactive compounds include alkaloids, saponins, and flavonoids that are believed to interact with the hypothalamic-pituitary-gonadal axis.
Animal studies have shown that aqueous extracts of Fadogia agrestis can increase serum testosterone levels in a dose-dependent manner, potentially by stimulating Leydig cell activity in the testes. Some research also suggests improvements in sexual behavior parameters such as mount frequency and intromission frequency in rodent models. These findings have driven significant interest among athletes and fitness enthusiasts seeking natural testosterone support.
Despite its popularity, human clinical data on Fadogia agrestis remain extremely limited. Importantly, animal studies have also raised safety concerns, including dose-dependent testicular toxicity at higher concentrations, with histological changes observed in testicular tissue. Users should exercise caution and consult healthcare providers before supplementation. It is frequently combined with Tongkat Ali in supplement stacks marketed for hormonal optimization.
Mechanism of Action
Proposed Androgenic Mechanisms
Fadogia agrestis is a West African shrub (family Rubiaceae) traditionally used as an aphrodisiac. Its aqueous stem extract contains bioactive alkaloids, saponins, flavonoids, and glycosides that are hypothesized to stimulate testosterone production. In rat models, Fadogia extract increased serum testosterone in a dose-dependent manner, possibly through direct stimulation of Leydig cell steroidogenesis by upregulating key enzymes in the testosterone biosynthetic pathway: StAR protein (steroidogenic acute regulatory protein), CYP11A1 (cholesterol side-chain cleavage), and 3-beta-HSD (3-beta-hydroxysteroid dehydrogenase) (PMID: 15970172).
Saponin-Mediated LH Mimicry
The steroidal saponins in Fadogia agrestis may act as partial agonists at the luteinizing hormone (LH) receptor on Leydig cells, mimicking LH signaling through the cAMP/PKA pathway. This would stimulate cholesterol mobilization into mitochondria via StAR and its subsequent conversion through the steroidogenic cascade (pregnenolone → progesterone → androstenedione → testosterone). However, this mechanism remains largely speculative and lacks direct receptor binding studies in human tissue.
Aphrodisiac & Reproductive Effects
In animal studies, Fadogia agrestis extract increased mount frequency, intromission frequency, and reduced mount/ejaculatory latency, effects consistent with elevated androgen signaling. These behavioral changes were accompanied by increased testicular weight and elevated epididymal sperm density, suggesting trophic effects on spermatogenesis potentially mediated through androgen receptor (AR) activation in Sertoli and germ cells.
Safety Considerations & Toxicity Signals
Notably, higher doses (100 mg/kg and above in rats) produced histopathological changes in testicular architecture, including seminiferous tubule degeneration and Leydig cell hyperplasia, raising concerns about dose-dependent toxicity. Elevated serum phosphatase levels at higher doses suggest possible organ stress. Human safety data remains extremely limited, and the dose-response relationship for efficacy versus toxicity in humans is undefined (PMID: 15970172).
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Reported Effects
Individual Variability:: Results appear highly individual—some users experience dramatic effects while others report zero benefits, possibly due to baseline testosterone levels or product quality. Synergistic Use:: Most positive reports involve stacking with Tongkat Ali (400mg) and other supplements like zinc, boron, and vitamin D rather than using Fadogia alone. Timing of Effects:: When effective, users typically notice changes within 2-4 weeks, with testosterone peaks occurring around 2-3 months of consistent use. Questionable Solo Use:: Many experienced users question whether Fadogia specifically contributes to results or if benefits come primarily from lifestyle changes and other supplements in the stack
- Results appear highly individual—some users experience dramatic effects while others report zero benefits, possibly due to baseline testosterone levels or product quality
- Most positive reports involve stacking with Tongkat Ali (400mg) and other supplements like zinc, boron, and vitamin D rather than using Fadogia alone
- When effective, users typically notice changes within 2-4 weeks, with testosterone peaks occurring around 2-3 months of consistent use
- Many experienced users question whether Fadogia specifically contributes to results or if benefits come primarily from lifestyle changes and other supplements in the stack
Safety Profile
Safety Profile: Fadogia Agrestis
Common Side Effects
- Gastrointestinal discomfort including nausea, cramping, and diarrhea
- Increased body temperature or sensation of warmth
- Mild headache
- Increased libido (may be unwanted in some contexts)
- Changes in mood including irritability or restlessness
- Altered sleep patterns
Serious Adverse Effects
- Testicular toxicity: Animal studies (rats) demonstrate dose-dependent testicular damage including seminiferous tubule degeneration, decreased sperm counts, and elevated testicular cholesterol at doses of 50-100 mg/kg; reversibility uncertain
- Hepatotoxicity: Elevated liver enzymes observed in animal studies; saponin and alkaloid content may be hepatotoxic with chronic use
- Nephrotoxicity: Animal data suggest potential renal damage at higher doses
- Hormonal disruption: Paradoxical suppression of testosterone at high doses despite enhancement at lower doses
- Heavy metal contamination risk: Unregulated supplements may contain toxic levels of lead, mercury, or arsenic
- No human clinical trials: All serious adverse effect data extrapolated from animal studies; human risk profile remains unknown
Contraindications
- Pre-existing testicular disorders or male infertility
- Liver disease or elevated liver enzymes
- Kidney disease or renal impairment
- Hormone-sensitive cancers (prostate, breast) due to androgenic activity
- Pregnancy and breastfeeding (potential endocrine disruption and unknown teratogenic risk)
- Children and adolescents under 18 years
- Concurrent use of anabolic steroids or testosterone replacement therapy
Drug Interactions
- Testosterone and androgenic compounds: Additive androgenic effects; risk of hormonal imbalance, erythrocytosis, and cardiovascular strain
- 5-alpha reductase inhibitors (finasteride, dutasteride): May counteract the intended purpose of these medications
- Hepatotoxic drugs (acetaminophen, statins, certain antibiotics): Additive liver stress; monitor LFTs
- Aromatase inhibitors: Combined androgenic effects may cause estrogen imbalance
- Anticoagulants: Some saponins have platelet-modulating activity; monitor for altered coagulation
- Antihypertensives: Potential for blood pressure changes due to hormonal and vascular effects
Population-Specific Considerations
- Males seeking testosterone enhancement: Primary user demographic; strict dose limits recommended (typically 100-600 mg/day of extract); cycle for no more than 6-8 weeks with equal break periods
- Females: Avoid due to androgenic effects including virilization risk (deepening voice, hirsutism, acne)
- Elderly males: Higher baseline risk of prostate issues; PSA monitoring recommended if using
- Pediatric/Adolescents: Strictly contraindicated; may disrupt normal pubertal hormonal development
- Pregnant/Lactating: Absolutely contraindicated
- Critical safety note: No peer-reviewed human clinical trials exist. All safety data is extrapolated from rodent studies and traditional use reports. Users assume significant unknown risk. Third-party testing of supplements essential to verify purity and absence of contaminants.
Pharmacokinetic Profile
Quick Start
- Typical Dose
- Most commonly reported dose is 400-600mg daily, though some products contain up to 1,200mg per serving
Safety Profile
Common Side Effects
- Organ Toxicity:: Major concern about potential liver and kidney damage based on animal studies, with users advised to get regular bloodwork to monitor enzyme levels
- Sexual Dysfunction:: Some users report paradoxical erectile dysfunction, reduced libido, and testicular shrinkage after prolonged use or when discontinuing
- Quality Control Issues:: Significant contamination and dosing inconsistency in commercial products, with many supplements containing minimal or no active compounds
- Interaction Effects:: High zinc doses (50mg) commonly stacked with Fadogia can cause copper deficiency; combination with SSRIs may exacerbate sexual side effects
References (5)
- [1]Effects of oral administration of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem on some testicular function indices of male rats
→ Study in male rats showed that Fadogia agrestis extract (18-100 mg/kg) for 28 days significantly increased testicular weight ratio, cholesterol, and testosterone-related enzyme activities, suggesting potential effects on testicular function.
- [2]Aphrodisiac potentials of the aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male albino rats
→ Animal study found that Fadogia agrestis extract increased mount frequency, intromission frequency, prolonged ejaculatory latency, and significantly increased serum testosterone concentrations in a dose-dependent manner in male rats.
- [3]Mode of cellular toxicity of aqueous extract of Fadogia agrestis (Schweinf. Ex Hiern) stem in male rat liver and kidney
→ Toxicity study in rats revealed that Fadogia agrestis extract caused significant changes in liver and kidney enzyme activities and increased oxidative stress markers, raising concerns about potential hepatic and renal toxicity.
- [4]Quantification of Phenolic Compounds from Fadogia agrestis and Dietary Supplements using UHPLC-PDA-MS
→ Analytical study identified and quantified 11 phenolic compounds in Fadogia agrestis samples and found that only 12 of 17 tested dietary supplements contained phenolic compounds in range of 0.3-2.7 mg per dose, highlighting quality control issues.
- [5]Glycosides of ursane-type triterpenoid, benzophenone, and iridoid from Vangueria agrestis (Fadogia agrestis) and their anti-infective activities
→ Phytochemical analysis isolated seven compounds from Fadogia agrestis roots, including novel metabolites, with some showing inhibitory effects against Trypanosoma brucei, suggesting potential anti-parasitic properties.
FAD (Flavin Adenine Dinucleotide)
Flavin Adenine Dinucleotide (FAD) is a critical redox-active coenzyme derived from riboflavin (vitamin B2) that functions as a prosthetic group for various flav
Fasoracetam
Fasoracetam is a nootropic compound in the racetam family that modulates metabotropic glutamate receptors (mGluRs) and upregulates GABA-B receptors. It has been